Literature DB >> 18649881

Hypothyroidism is not associated with increased carotid atherosclerosis when cardiovascular risk factors are accounted for in hyperlipidemic patients.

Françoise Chiche1, Christel Jublanc, Mathieu Coudert, Valérie Carreau, Jean-François Kahn, Eric Bruckert.   

Abstract

Overt hypothyroidism is associated with an increased prevalence of cardiovascular heart disease (CHD). The role of subclinical hypothyroidism as risk factor for cardiovascular diseases is supported by recent meta-analysis. However it still remains to be established whether hypothyroidism favors atherosclerosis independently of its effects on cardiovascular risk factors, such as hypercholesterolemia or hypertension. To assess whether hypothyroidism might be a risk factor per se, we analyzed carotid lesions assessed by US examination in two large populations with similar risk factors and displaying hypo- or euthyroidism. We selected, among a population of patients referred for assessment of hyperlipidemia, 794 hypothyroid patients (TSH>4mU/L), and 1588 euthyroid patients matched for the main cardiovascular risk factors (age, gender, lipid levels, hypertension, diabetes, smoking habits and obesity). All the patients had evaluation of their arterial carotid plaques, and about half of them had measurement of carotid intima-media thickness (IMT). Our hypothyroid population included 90% of patients with normal FT4 levels (subclinical hypothyroidism). We found that neither prevalence nor severity of carotid plaques nor carotid IMT were significantly different between hypothyroid patients and controls. To assess whether thyroid hormones may predict carotid atherosclerosis, we performed multivariate regression analyses, and we showed that, in both populations of hypothyroid and euthyroid patients, neither the TSH values nor the FT4 concentrations were independent risk factors for carotid atherosclerosis. In conclusion, we showed that, among a population of hyperlipidemic patients, hypothyroidism is not associated with an increased risk for carotid atherosclerosis when cardiovascular risk factors are accounted for.

Entities:  

Mesh:

Year:  2008        PMID: 18649881     DOI: 10.1016/j.atherosclerosis.2008.06.011

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  8 in total

Review 1.  Therapeutic approaches to drug targets in atherosclerosis.

Authors:  Prasad G Jamkhande; Prakash G Chandak; Shashikant C Dhawale; Sonal R Barde; Priti S Tidke; Ram S Sakhare
Journal:  Saudi Pharm J       Date:  2013-11-05       Impact factor: 4.330

2.  Association between blood lead levels and metabolic syndrome considering the effect of the thyroid-stimulating hormone based on the 2013 Korea National health and nutrition examination survey.

Authors:  Ji Yoon Choi; Da-An Huh; Kyong Whan Moon
Journal:  PLoS One       Date:  2020-12-31       Impact factor: 3.240

3.  No evidence of association between subclinical thyroid disorders and common carotid intima medial thickness or atherosclerotic plaque.

Authors:  A P Delitala; F Filigheddu; M Orrù; M AlGhatrif; M Steri; M G Pilia; A Scuteri; M Lobina; M G Piras; G Delitala; E G Lakatta; D Schlessinger; F Cucca
Journal:  Nutr Metab Cardiovasc Dis       Date:  2015-10-21       Impact factor: 4.222

4.  A Study of the Extended Lipid Profile including Oxidized LDL, Small Dense LDL, Lipoprotein (a) and Apolipoproteins in the Assessment of Cardiovascular Risk in Hypothyroid Patients.

Authors:  Sanjiv Kumar Bansal; Rakhee Yadav
Journal:  J Clin Diagn Res       Date:  2016-06-01

5.  Effects of thyroid dysfunction on lipid profile.

Authors:  C V Rizos; M S Elisaf; E N Liberopoulos
Journal:  Open Cardiovasc Med J       Date:  2011-02-24

6.  Serum Lipid Transfer Proteins in Hypothyreotic Patients Are Inversely Correlated with Thyroid-Stimulating Hormone (TSH) Levels.

Authors:  Anna Skoczyńska; Anna Wojakowska; Barbara Turczyn; Katarzyna Zatońska; Maria Wołyniec; Natalia Rogala; Andrzej Szuba; Grażyna Bednarek-Tupikowska
Journal:  Med Sci Monit       Date:  2016-11-30

7.  FMD and CIMT: Surrogate Markers of Atherosclerosis in Subclinical and Overt Hypothyroidism in Sub Himalyan Region.

Authors:  Bandana Kumari; Bhupender Kumar; Dalip Gupta; Neeraj Ganju
Journal:  Indian J Endocrinol Metab       Date:  2021-10-26

8.  Noninvasive indicators of atherosclerosis in subclinical hypothyroidism.

Authors:  Ismail Dogu Kilic; Halil Tanriverdi; Semin Fenkci; Fulya Akin; Sukriye Uslu; Asuman Kaftan
Journal:  Indian J Endocrinol Metab       Date:  2013-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.